Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity
Wissam Ghusn, Alan De la Rosa, Daniel Sacoto, et al.
JAMA Network Open (2022) Vol. 5, Iss. 9, pp. e2231982-e2231982
Open Access | Times Cited: 128

Showing 1-25 of 128 citing articles:

Integrative neurocircuits that control metabolism and food intake
Jens C. Brüning, Henning Fenselau
Science (2023) Vol. 381, Iss. 6665
Closed Access | Times Cited: 73
Obesogens: a unifying theory for the global rise in obesity
Jerrold J. Heindel, Robert H. Lustig, Sarah Howard, et al.
International Journal of Obesity (2024) Vol. 48, Iss. 4, pp. 449-460
Open Access | Times Cited: 33
Effectiveness and safety of drugs for obesity
Kristina H. Lewis, Caroline E Sloan, Daniel H. Bessesen, et al.
BMJ (2024), pp. e072686-e072686
Open Access | Times Cited: 22
A systematic review of the effect of semaglutide on lean mass: insights from clinical trials
Alexia Bikou, Foteini Dermiki‐Gkana, Michail Penteris, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 5, pp. 611-619
Closed Access | Times Cited: 16
Medical therapy to treat obesity and optimize fertility in women of reproductive age: a narrative review
Janelle Duah, David B. Seifer
Reproductive Biology and Endocrinology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Long‐Term Weight Loss Outcomes in a Virtual Weight Care Clinic Prescribing a Broad Range of Medications Alongside Behavior Change
Jennifer M. Clark, Brooke J. Smith, Jessie Juusola, et al.
Obesity Science & Practice (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity
Linong Ji, Hongwei� Jiang, Zhi-Feng Cheng, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 29
Diabetes Mellitus Remission in Patients with BMI > 50 kg/m2 after Bariatric Surgeries: A Real-World Multi-Centered Study
Wissam Ghusn, Kayla Ikemiya, Karim Al Annan, et al.
Obesity Surgery (2023) Vol. 33, Iss. 6, pp. 1838-1845
Closed Access | Times Cited: 25
Type-2 diabetes mellitus remission prediction models after Roux-En-Y gastric bypass and sleeve gastrectomy based on disease severity scores
Wissam Ghusn, Karl Hage, Robert A. Vierkant, et al.
Diabetes Research and Clinical Practice (2024) Vol. 208, pp. 111091-111091
Closed Access | Times Cited: 13
Weight loss and cardiovascular disease risk outcomes of semaglutide: a one-year multicentered study
Wissam Ghusn, Sima Fansa, Diego Añazco, et al.
International Journal of Obesity (2024) Vol. 48, Iss. 5, pp. 662-667
Closed Access | Times Cited: 13
One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical Practice
Hamlet Gasoyan, Elizabeth R. Pfoh, Rebecca Schulte, et al.
JAMA Network Open (2024) Vol. 7, Iss. 9, pp. e2433326-e2433326
Open Access | Times Cited: 13
Semaglutide 2.4 mg clinical outcomes in patients with obesity or overweight in a real‐world setting: A 6‐month retrospective study in the United States (SCOPE)
Aleksandrina Ruseva, Wojciech Michalak, Zhenxiang Zhao, et al.
Obesity Science & Practice (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Semaglutide and Tirzepatide for the Management of Weight Recurrence After Sleeve Gastrectomy: A Retrospective Cohort Study
Mohammad H. Jamal, Mohsen Alhashemi, Carol Dsouza, et al.
Obesity Surgery (2024) Vol. 34, Iss. 4, pp. 1324-1332
Closed Access | Times Cited: 12
Effectiveness and care continuity in an app‐based, glucagon‐like peptide‐1 receptor agonist‐supported weight‐loss service for women with overweight and obesity in the UK: A real‐world retrospective cohort analysis
Louis Talay, Matt Vickers
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 7, pp. 2984-2987
Closed Access | Times Cited: 10
Implementation of Obesity Science Into Clinical Practice: A Scientific Statement From the American Heart Association
Deepika Laddu, Ian J. Neeland, Mercedes R. Carnethon, et al.
Circulation (2024) Vol. 150, Iss. 1
Open Access | Times Cited: 10
Cardiovascular Protective Properties of GLP-1 Receptor Agonists: More than Just Diabetic and Weight Loss Drugs
Richard Le, Mau T. Nguyen, Momina A. Allahwala, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4674-4674
Open Access | Times Cited: 10
Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks
Wissam Ghusn, Maria D. Hurtado
Obesity Pillars (2024) Vol. 12, pp. 100127-100127
Open Access | Times Cited: 10
Direct-to-Consumer Platforms for New Antiobesity Medications — Concerns and Potential Opportunities
Ilya Golovaty, Scott Hagan
New England Journal of Medicine (2024) Vol. 390, Iss. 8, pp. 677-680
Closed Access | Times Cited: 9
Estimating the lives that could be saved by expanded access to weight-loss drugs
Abhishek Pandey, Ye Yang, Chad R. Wells, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 43
Open Access | Times Cited: 8
Factors associated with weight loss response to GLP-1 analogues for obesity treatment: a retrospective cohort analysis
P. G. Squire, James Naude, Ali Zentner, et al.
BMJ Open (2025) Vol. 15, Iss. 1, pp. e089477-e089477
Open Access | Times Cited: 1
Weight-centric treatment of type 2 diabetes mellitus
Wissam Ghusn, Maria D. Hurtado, Andrés Acosta
Obesity Pillars (2022) Vol. 4, pp. 100045-100045
Open Access | Times Cited: 29
Advances in Anti-obesity Pharmacotherapy: Current Treatments, Emerging Therapies, and Challenges
Skyler Brandfon, Adi Eylon, Deepesh Khanna, et al.
Cureus (2023)
Open Access | Times Cited: 20
Intestinal Enteroendocrine Cells: Present and Future Druggable Targets
Roger Atanga, Varsha Singh, Julie In
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8836-8836
Open Access | Times Cited: 18
Enteroendocrine cell regulation of the gut-brain axis
Joshua R. Barton, Anne Londregan, Tyler D. Alexander, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 18
The association between microvascular and macrovascular diseases and diabetes remission after bariatric surgery
Wissam Ghusn, Marita Salame, Lea N. Sayegh, et al.
Surgical Endoscopy (2024) Vol. 38, Iss. 4, pp. 1835-1843
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top